Context. Breast cancer survivors (BCS) face adverse physical and psychological symptoms, often co-occurring. Biologic and psychological factors may link symptoms within clusters, distinguishable by prevalence and/or severity. Few studies have examined the effects of behavioral interventions or treatment of symptom clusters.
Introduction
Breast cancer is expected to affect one-in-eight women during her lifetime. 1 Even with advances in cancer treatments and decreased mortality rates, 2 breast cancer remains a major public health concern 3 in part because of the multiple debilitating symptoms as a result of surgery, chemotherapy, radiation therapy, and/or biologic therapy. 4 Often, breast cancer survivors (BCS) are plagued by adverse physical (fatigue, pain, and sleep disturbances) and psychological symptoms (stress, anxiety, alteration in cognitive functioning, depression, and fear of recurrence [FOR] ) that may remain and/or occur years after treatment completion, 5 reducing both quality of life and functionality. Although BCS suffer from multiple adverse symptoms, fatigue is reported to be the most debilitating, 9, 10 often lasting up to 10 years after diagnosis. 11 Pain is reported by up to 33% of BCS after curative therapy. 9 The prevalence of sleep disturbances are reported to be twice as high among BCS in comparison with the general population. 12, 13 It is estimated that up to 70% of cancer survivors experience six or more co-occurring symptoms. 14 With this prevalence, there is increasing evidence to support examining symptom clusters among BCS to improve effective therapies. 15, 16 The term ''symptom cluster'' was defined over a decade ago as multiple concurrent and related symptoms that are not required to have shared etiology. 17 Evidence of specific symptom clusters among BCS were reported in the following: psychological/mood symptoms in seven studies, 5,16,18e22 fatigue emerged as a cluster in six studies, 5,18e22 somatic or physical symptoms (e.g., pain) emerged in four studies, 18e20,23 gastrointestinal symptoms emerged in three studies, 5, 16, 24 sleep disturbance emerged in two studies, 18, 22 and cognitive impairment emerged in two studies. 21, 24 A hormonal cluster observed by Roiland and Heidrich 18 is the only cluster without a match in other symptom cluster studies. Although the mechanism for symptom clusters is not completely understood, it has been suggested that biologic mechanisms 18 and psychological factors, such as stress, 19, 25 may link symptoms together within clusters, distinguishable by prevalence and/or severity.
Although pharmacologic and psychological treatments are used to treat symptoms, few have examined the treatment of symptom clusters. 20 Nonpharmacologic complementary and alternative medicine therapies, such as Mindfulness-Based Stress Reduction (MBSR), 23 hold promise as a clinical treatment for the reduction of multiple co-occurring symptoms among BCS. Evidence supports MBSR as an effective clinical treatment for reducing individual symptoms of fatigue and mood disturbance, 21 depression and anxiety, 22 ,24,26 and FOR. 22 Although this is the first large trial assessing the effects of MBSR(BC) across multiple symptom clusters in BCS, in our previous trial among 84 BCS, withingroup symptom cluster improvement occurred after the MBSR(BC) program 5 using the M.D. Anderson Symptom Inventory. 27 Three clusters emerged: gastrointestinal, cognitive/psychological, and fatigue. 5 A limitation of this past study was the small sample size, resulting in insufficient power to detect between-group effects and preventing implementation of a more robust statistical method, such as structural equation modeling. Therefore, this current trial corrects for this limitation by implementing erroraccounting models of factor analysis and structural equation modeling to allow for tests of symptom cooccurrence and tests of treatment effects within the same model. The aim of this study was to identify symptom clusters among post-treatment BCS and test whether these symptom clusters improved following the MBSR(BC) program at the six-and 12-week follow-up compared with usual care (UC). This purpose fits well with the central aim of this clinical trial: to determine the efficacy of MBSR(BC) in improving outcomes.
Methods

Sample and Setting
Three hundred twenty-two (n ¼ 322) BCS aged $ 21 years, with a diagnosis of Stage 0eIII BC and within two weeks to two years off treatment were recruited from the Moffitt Cancer Center, Carol and Frank Morsani Center for Advanced Healthcare, and the Life Hope Medical Group, located in Tampa, FL. Exclusion criteria included a diagnosis of Stage IV BC, severe mental disorder, and/or BC recurrence.
Procedures
Study Design and Randomization. A two-armed randomized controlled design was used to randomize 322 BCS to the MBSR(BC) program or UC. Randomization was stratified by type of surgery (lumpectomy vs. mastectomy), adjuvant BC treatment (chemotherapy with or without radiation vs. radiation alone), and stage of BC (Stage 0/I vs. II/III).
Recruitment and Data Collection Procedures. The study protocol was approved by the Institutional Review Board at the University of South Florida and scientific review committee at the Moffitt Cancer Center. BCS meeting inclusion criteria and if interested in the study were invited to an orientation session during which informed consent was obtained along with baseline assessments followed by randomization. At baseline and at six and 12 weeks, demographic data, clinical history, measures of psychological and physical symptoms, and QOL were collected.
MBSR(BC) Intervention. The MBSR(BC) program, modeled after the MBSR program developed by Jon Kabat-Zinn et al., 28, 29 was adapted to assist breast cancer patients in taking an active role in stress reduction and symptom management through the selfregulatory process of meditation. 22 The MBSR(BC) intervention consists of three components: 1) educational material related to relaxation, meditation, the mind-body connection, and a healthy lifestyle for survivors, 2) practice of meditation in group meetings and homework assignments, and 3) group processes related to barriers to the practice of meditation and supportive group interaction. 30 A psychologist trained in MBSR taught the six-week, two-hour per week sessions that included training in formal meditation techniques (sitting meditation, body scan, gentle Hatha yoga, and walking meditation), along with informal techniques of integrating mindfulness into daily life activities. BCS were requested to formally and informally practice the meditative techniques for 15e45 minutes per day and to record their practice times in a daily diary. A manual and compact discs were provided to guide home practice.
Fidelity. Intervention sessions conducted by a single instructor were monitored weekly by a research assistant, who recorded time and delivery of the components of the two-hour class sessions on a fidelity checklist.
Usual Care. UC participants continued standard posttreatment clinic visits and were asked to refrain from practicing meditation, yoga techniques, and MBSR(BC) during study enrollment. They were offered the MBSR(BC) intervention within six months after completion of the study.
Measures
Demographic Data and Clinical History. Demographic data on age, ethnicity, educational achievement, marital status, income, and employment status and clinical history data on cancer type, date of diagnosis, and treatments were collected at baseline and updated at six and 12 weeks.
Symptoms
Worry and Fear of Cancer Recurrence. The Concerns About Recurrence Scale 31 consists of two subscales: overall FOR and nature of FOR. Higher scores demonstrate greater overall fear and worry. 31 Concerns About
Recurrence Scale has shown good reliability (0.87) and validity for breast cancer subjects.
31
Depression. The Center for Epidemiological Studies Depression Scale measured depressive symptomatology during the past week 32 and measures frequency of depressive feelings and behaviors. A reliability coefficient of 0.92 has been reported for breast cancer subjects 32 and satisfactory validity has been demonstrated in many studies across different populations. 33, 34 Anxiety. State-Trait Anxiety Inventory 35 was used to measure ''state'' or situational anxiety. The state anxiety subscale includes 20 items that measure present anxiety. It has reported high internal consistency (0.95) and convergent validity with other measures of anxiety. 35 Perceived Stress. The Perceived Stress Scale 36 was used to assess how often in the past month the subject appraised life situations as ''stressful.'' The scale has demonstrated both good reliability (0.84e0.86) and good validity. 36 Mindfulness. Cognitive and Affective Mindfulness Scale-Revised measured mindfulness 37 and measures four domains: attention, present-focus, awareness, and acceptance/nonjudgment. It has demonstrated an acceptable level of internal consistency (alpha 0.74e0.77) and evidence of convergent and discriminant validity with other measures of mindfulness. 37 Symptom Severity. Symptom severity was measured using the M.D. Anderson Symptom Inventory, 27 which measures the severity of symptoms and the degree that they may interfere with daily functioning. It has demonstrated satisfactory consistency ($0.85) and test-retest reliability ($0.76). 38 Sleep Quality. Sleep quality was measured by the Pittsburgh Sleep Quality Index, 39 which measures seven domains of sleep: quality, latency, duration, efficiency, disturbances, use of sleep medications, and daytime sleep function. It has demonstrated adequate reliability ranging from 0.70 to 0.78 for sleep disturbance. 39 Fatigue. Fatigue was measured using the Fatigue Symptom Inventory, 40 which evaluates the perceived level of fatigue by assessing the perceived severity, frequency, and interference with daily functioning. It was found to have good internal consistency, with alpha coefficients greater than 0.90. 40 Pain. Pain was measured by the Brief Pain Inventory, 41 which examines pain intensity and interference.
Higher scores are associated with greater pain severity and interference. It has demonstrated reliability coefficients from 0.82 to 0.95. 41 Cognitive Functioning. The Everyday Cognition (ECog) scale is a multidimensional instrument measuring impairment and change of everyday functioning relevant to several neuropsychological domains. 42 The scale provides a global score and six subscales including everyday memory, language, visuospatial abilities, planning, organization, and divided attention. It has reported adequate reliability (0.82) and convergent validity and external validity. 42 Health-Related Quality of Life. Health-related QOL was measured by the Medical Outcomes Studies ShortForm General Health Survey (SF-36), 43 which has eight subscales that assess physical functioning, physical role functioning, bodily pain, general health, vitality, social functioning, emotional role functioning, and mental health. Estimates of reliability range from 0.62 to 0.94 in different study populations, and most scores have exceeded 0.80. Test-retest reliability estimates range from 0.43 to 0.90. 43 
Statistical Analyses
A three-step analytic process was used to assess the central aim of this study. Each step adopted a latent variable approach. The first step was to identify the clustering of symptoms using baseline data (before randomization to the MBSR(BC) program). Exploratory factor analysis was used to identify which measures or items within measures ''clustered'' together. Multiple combinations of measures and items were tested. The model with the lowest Bayesian Information Criterion was selected. This model was tested at each additional time point using root mean square error of approximation (RMSEA), comparative fit index (CFI), and the standardized root mean square residual (SRMR). When the CFI coefficient was greater than 0.95, the RMSEA less than 0.07, and the SRMR less than 0.08, the model fit was considered acceptable. 44, 45 The second step of the analysis used a conditional structural equation model to test the beneficial effects of MBSR(BC) at six weeks (immediately post-MBSR(BC) training). Using intent-to-treat principles in this model, MBSR(BC) was tested as a moderator of symptom cluster improvement (using the latent variables established in the factor analysis of Step 1). RMSEA, CFI, and the SRMR were used to evaluate model fit.
The third analytic step was to test for the follow-up effects of MBSR(BC). For this step, the same structural equation modeling (SEM) strategy was used as identified in Step 2 with symptom cluster improvement measured from six weeks to 12 weeks. Although this approach (splitting the baseline to six weeks and six weeks to 12 weeks) was not ideal, we did not have sufficient power to run a growth curve model with multiple latent variables and a treatment moderator.
Model estimation was conducted in Mplus, v. 7.1 46 using full information maximum likelihood estimation to benefit from all available information in the data. That is, participants with missing information were included in the analyses under the assumption of missing at random (i.e., missingness conditional on observed variables).
Results
Participant Characteristics
Three hundred twenty-two BCS were enrolled in the study, with 299 completing. There were no statistically significant differences between groups at baseline. The mean age was 56.6 years and the majority were white non-Hispanic (69.4%), married (64.4%), diagnosed with Stage II BC (35.7%), and received a mastectomy (53.4%) and radiation and chemotherapy (35.7%). For additional demographics, clinical history characteristics, and CONSORT data, refer to Lengacher et al. 47 Step 1 Results Figure 1 point toward the indicators that assessed each symptom cluster. The coefficients attached to each arrow represent standardized beta weights, which indicate the strength of the relationship between the measure and the cluster. Because the acceptability of this model was supported, the identical structure was used to test the MBSR(BC) effects at all three time points (baseline, six weeks, and 12 weeks). Although pain is often viewed as a single symptom and not a traditional symptom cluster, in this trial it was evaluated as a latent variable in the factor analysis because multiple dimensions of pain were measured.
Step 2 Results
To test whether the UC or MBSR(BC) group differed before the intervention, the experimental condition was tested as a covariate for the best-fitting cluster model at baseline. Even with the covariate added, model fit remained adequate (CFI ¼ 0.97, RMSEA ¼ 0.066, and SRMR ¼ 0.05). Evidence emerged of a potential baseline group difference on the psychological cluster (anxiety, depression, perceived stress, and emotional well-being) (P < 0.05). The remaining clusters did not differ statistically (all P's > 0.05). As a result of the difference in the psychological cluster, the decision was made to account for baseline values using difference scores for all outcomes at the six-week and 12-week time points. To determine if the symptom cluster model established at baseline remained an acceptably fitting model using difference scores, the baseline to sixweek difference scores were tested using confirmatory factor analysis. The model fit remained acceptable. In fact, fit indices improved somewhat (CFI ¼ 0.99, RMSEA ¼ 0.03, and SRMR ¼ 0.05). When the model was tested conditionally with experimental assignment used as a covariate, MBSR(BC) demonstrated evidence of effectiveness. Improvement in both the psychological (anxiety, depression, perceived stress and QOL, emotional well-being) (P ¼ 0.007) and fatigue (fatigue, sleep, and drowsiness) (P < 0.001) clusters were related to assignment. Specifically, participants who received the MBSR(BC) training improved Figure 2 diagrams the sixweek model conditional on experimental assignment. Tables 1e4 display the mean scores of each measure composing the clusters by random assignment.
Step 3 Results
To determine whether improvement continued between the end of MBSR(BC) training (six weeks) and the 12-week follow-up point, the same initial factor analytic model was tested using difference scores between six and 12 weeks (Fig. 3) . Although the fit indices for this model were not as good as the six-week model, they remained acceptable (CFI ¼ 0.96, RMSEA ¼ 0.04, and SRMR ¼ 0.05). When tested conditionally on experimental condition, general symptom cluster improvement did not vary (psychological, P ¼ 0.84; fatigue, P ¼ 0.80; cognition, P ¼ 0.26; and pain, P ¼ 0.09). It is important to note that a lack of MBSR(BC)-related improvement on the 12-week difference scores does not mean that the observed six-week improvement disappeared. Rather, it means that the degree of improvement between those time points was not contingent on MBSR(BC). Tables 1e4 display the mean scores of each measure composing the clusters by random assignment.
Discussion
This study is the first identified clinical trial that tested the effects of MBSR(BC) across multiple symptom clusters in post-treatment BCS. Building on our previous symptom cluster research, this current trial used multiple specific symptom measures to define the clusters. It also tested whether reduction in the symptom cluster experience were the result of the MBSR(BC) program and assessed whether the symptom cluster reductions continued at 12 weeks.
This study also aimed to advance symptom cluster research and research on effective clinical treatment of symptom clusters among BCS by use of an effective nonpharmacologic intervention. Our results identified that immediate symptom cluster improvement occurred during the six-week MBSR(BC) training period, and although it generally did not increase after the six-week time point, improvements were generally sustained to 12 weeks.
The results of this trial first support the existence of multiple symptom clusters among post-treatment BCS. The symptom clusters that emerged replicated the two most commonly occurring symptom clusters in the literature: psychological symptoms and fatigue symptoms 5,18e20,22,24 and two other clusters also were observed in multiple studies: pain symptoms 18e21 and cognitive symptoms. 22, 26 The existence of these co-existing symptoms suggests, for example, a patient experiencing fatigue may also experience drowsiness, resulting from sleep disruption. In addition, BCS who experience depression may also experience stress and anxiety, affecting emotional well-being. Although previous research has explored clustering of symptoms, few have focused solely on BCS.
A second significant outcome of this trial was evidence that the MBSR(BC) intervention had a positive effect on the improvement of BCS-specific symptom clusters, the psychological and fatigue clusters, with medium-sized effects (Cohen's d ¼ 0.34 and 0.50, respectively). Clinically, this is an important finding that MBSR(BC) not only improves individual symptoms but concurrently is improving ''clusters'' of symptoms. There are no identified studies testing MBSR across multiple symptom clusters in post-treatment BCS, for comparison. This current trial supports the effectiveness of MBSR(BC) in reducing fatigue in BCS, as reported in our preliminary study. 5 One surprising outcome was that differences between groups were not observed in the ''cognitive'' cluster, which included a measure of mindfulness. However, this was not a ''mindfulness'' cluster, as a mindfulness measure shared sufficient variance with a ''memory'' measure to create the latent variable labeled the ''cognitive'' cluster. Other studies should directly measure whether mindfulness improved in our participants using the multiple measures of mindfulness used in this study.
Although a component of all models tested, statistically significant differences between MBSR(BC) and UC were not observed with the pain cluster. In previous studies, the effect of MBSR on pain symptoms has not been absolute but has been shown to vary based on pain condition. 48 In the case of our sample of early-stage cancer survivors, pain reports were relatively low compared with other cancer samples with more advanced stage patients 49 introducing the possibility that our study was not sensitive enough to detect pain symptom reductions.
A third major outcome of this trial was that symptom cluster improvement occurred predominately during the period of time of the six-week MBSR(BC) training. Although improvements did not diminish from six to 12 weeks, they did not differ between six-week and 12-week follow-up assessment, possibly because of floor 
Potential Clinical Implications and Directions for Future Research
This large randomized trial provides evidence that physical, psychological, and cognitive symptom clusters exist among post-treatment BCS. Our results indicate that the symptom clusters identified at baseline were sustained for 12 weeks, with an immediate benefit within the training period. Clinically, this study provides evidence for clinicians to assess and screen for individual and clinically aligned related symptoms and determine if interventions like MBSR(BC) can be offered to improve multiple individual symptoms and clusters of symptoms. Future research should continue to evaluate MBSR(BC)'s effectiveness among more diverse populations, and other cancer populations, along with examining related biologic mechanisms of action of MBSR(BC).
Limitations
Although the three-step approach used in this study allowed for the observation of different effects at six and 12 weeks, a full growth curve model could have tested for curvilinear effects across all three time points. Unfortunately, using the latent variable approach of SEM, there was insufficient power to implement such a longitudinal model. Additionally, the cognitive cluster supported by the factor analyses should be interpreted cautiously. The ECog measure, which was a key component of the cognitive symptom cluster, was only administered to a subsample of our trial. The relationships observed for the cognitive cluster can be considered preliminary data for future work.
Conclusions
In conclusion, the findings from this trial are an encouraging step toward expanding survivorship care to meet the needs of the growing BCS population. Understanding symptom clusters in cancer survivors may result in greater therapeutic benefits by integrating treatments for concurrent symptoms, thus improving QOL. 50 In addition to QOL, multiple symptoms also affect prognosis and functional status of those with cancer. 51 The practice of complementary and alternative medicine therapies, such as MBSR(BC), show promise on a potentially large scale, for self-management of the multiple co-occurring adverse symptoms often experienced by BCS.
Previous research reports symptom clusters to vary according to cancer type, 52 disease stage, 52 and treatment type. 53 This trial adds to this existing evidence specific to BCS. It provides evidence that clusters of symptoms exist among BCS and identifies MBSR(BC) as an effective nonpharmacologic intervention, having the most improvement in the psychological and fatigue clusters, with the greatest benefit occurring during the six-week MBSR(BC) training. This study also demonstrated that although there were no additional improvements at 12 weeks, the improvements were sustained to 12 weeks.
Disclosures and Acknowledgments
